FDA Publishes Draft Guidance on Using URRAs in Combo Product Applications

To help the drug and device development industries account for human factors (HF) in their combination product trials, the FDA is releasing draft guidance on employing use-related risk analysis (URRA), a risk management tool that supports the HF engineering process.
Source: Drug Industry Daily